Club project to startup: Predictive Wear could receive up to $250,000 in matching funds to advance technology, commercialization

Predictive Wear LLC, an award-winning startup based on a technology developed by members of a Purdue University Weldon School of Biomedical Engineering-based student club, could receive an investment up to $250,000 in matching funds from Purdue Research Foundation's Foundry Investment Fund to help advance it to commercial viability—if the startup raises enough capital to match.
Predictive Wear co-founder Pablo Argote works on wearable technology that alerts patients and their doctors about possible medical complications.

Predictive Wear strives to turn everyday garments into lifesaving diagnostic tools by combining leading-edge advances in biomedical engineering, textiles, and predictive analytics. The startup is creating a wearable technology that helps patients and doctors better monitor and manage heart failure. Founders Pablo Argote and Dane Albaugh, alumni of Purdue’s Weldon School of Biomedical Engineering, along with a team of research engineers from the School, are passionate about bringing preventative medicine to the masses. The wearable technology is a smart compression legging which can conveniently track how a patient with heart failure is doing and report back to their doctor. 

The CDC estimates that 5.7 million suffer from heart failure in the United States, with half those patients dying within five years of their diagnosis. But heart failure is manageable, and Predictive Wear is working on technology to help detect heart failure complications quickly.

The startup spun out of a project that originated in Purdue MIND, a Purdue student organization founded in the Weldon School of Biomedical Engineering. The organization, advised by Hugh Lee, an assistant professor in the School, fosters opportunities for highly motivated Purdue undergraduate students to collaborate with professors and medical professionals to innovate and develop medically-focused technologies.

The Foundry Investment Fund provides critical capital for the transition from the discovery of a promising technology to founding a viable life sciences company. The funds are partial matching investments made in the companies by institutional and other investors.

“Through its matching fund program, the Foundry Investment Fund plays an important role in attracting interest in Purdue-affiliated life sciences companies,” said John Hanak, managing director of Purdue Ventures. “These companies are advancing quickly and have already received funding and investments from other sources making them eligible for this fund.”

Related:

Source:

Three Purdue startups could receive up to a total of $750,000 in matching funds to advance technologies, commercialization